Last year, the 上海龙凤ccepted registration applicat

tions for 222 domestically developed Class-1 new innovative drugs, while the figure

上海龙凤品茶微信s for 2017 were 402 and 181. Class-1 new drugs refer to drugs that have never been mark

eted in China or overseas, and innovative drugs means drugs with independent intellectual property rights.上海龙凤品茶微信

Among all the applications in 2018, 403 applications were for 198 drugs’ clinical trial approv

als, and 45 were for market approval for 24 drugs, while in 2017, 379 applications were for clinical trial appro

vals, involving 171 drugs, and 23 applications were for market approval, involving 10 drugs.

上海龙凤In 2018, 323 applications were for 115 chemical drugs, and 123 were for 106 biologics, while

in 2017, 324 applications were for 112 chemical drugs and 76 applications were for 68 biologics.

上海龙凤品茶微信Song Ruilin, executive president of the China Pharmaceutical Innovatio

n and Research Development Association, said Chinese pharmaceutical companies have ma

上海龙凤de remarkable progress in innovative drug research and development in the past few years,

especially in the area of biologics, thanks to their focus on innovation and homegrown R&D.

“In terms of pharmaceutical innovation, where we are now is completely different from where we were 15 years ago,” he said.上海龙凤

“Chinese companies used to focus on generics, but now they have been buil

ding up R&D capabilities and many invest generously in innovative drugs.”

上海龙凤品茶微信From 1949 to 2008, less than five domestically developed drugs were approved by Chine

se authorities, while from 2008 to 2018, the number increased by about 10 times to about 40, according to Song.上海龙凤

In 2018, nine Class-1 new drugs developed by domestic pharmaceutical companies wer

上海龙凤品茶微信e approved in China, figures from the National Medical Products Administration showed.

Most of the nine new drugs are treatments for cancer or rare diseases, or anti-virus therapies tha

t are urgently needed in medical practice, according to the National Medical Products Administration.

www.qianhuaeu.com